A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine
NCT03988088
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Migraine
Interventions
DRUG:
Lasmiditan
Sponsor
Eli Lilly and Company